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Abstract  
Purpose: This study aimed to: 1) describe the 4-item Early Activity Scale for Endurance (EASE) scores and 
Six-Minute Walk Test (6MWT) distances of children with cerebral palsy (CP) by functional ability level, 
sex, and age; and 2) examine the convergent validity of the EASE to the 6MWT. Methods: 708 children 
with CP (18-months to 12-years), GMFCS Levels I-V, completed the EASE, and 376 of the study 
participants, (3-12-years), GMFCS Levels I-III, also completed the 6MWT. Results: Children with CP 
present with variations in EASE scores and 6MWT distances based on GMFCS level and, to a lesser 
extent, age. The EASE and 6MWT demonstrate a statistically significant but low, positive correlation. 
Conclusions: Understanding the relationship between these outcomes and GMFCS levels and age, assists 
clinicians in establishing plans of care targeted at improving endurance for activity and functional 
walking capacity for children with CP.  
 
Background 
 Children with cerebral palsy (CP) typically present with lower levels of daily physical activity than 
children who are typically developing.1,2 Physical activity is defined as, “any bodily movement produced 
by skeletal muscles that requires energy expenditure.”3(p.126) For children with CP, impairments in muscle 
tone, postural control, strength, range of motion, and coordination may contribute to low levels of 
physical activity, poor endurance, and limitations in functional mobility.4 Specifically, reduced endurance 
has been identified as a main factor in decline in walking ability as children with cerebral palsy age,6-8 
and may impact a child’s ability to fully participate in home, school, and community activities.9 Because 
of these trends, it is important for rehabilitation providers to assess endurance of children with CP, to 
track changes over time, and attempt to mediate further functional decline. Clinicians rely on readily 
available, easily administered measures to establish a baseline and measure change over time. The Early 
Activity Scale for Endurance (EASE)10, 11 (4 and 10 item versions) and six-minute walk test (6MWT)12 are 
designed for these purposes.    
 The 4-item EASE is a short, parent completed measure of perceived endurance for activity for 
children. The four items are: 1) My child’s physical activity level is similar to other children his or her age, 
2) My child has a high physical energy level and rarely needs to take rests when moving himself or 
herself around during daily activities and play time, 3) My child does enough activity so that he or she is 
breathing quickly or gets flushing in his or her face at least one time each day, and 4) My child spends a 
lot of his or her play or free time doing activities that require lots of physical energy. Parents rate each 
item on a scale from 1 (Never) to 5 (Always), with higher scores indicating greater endurance for activity. 
The average score for the four items is used for analysis. Acceptable test-retest reliability (ICC = 0.95, 
95% CI: 0.90-0.98) and validity of the 10-item EASE have been reported with young children with CP.10,13 
Calculations from the same data for the 4-item EASE demonstrated acceptable but slightly lower test-
retest reliability (ICC = 0.75 (95% CI 0.54-0.87).11 The 4-item and the 10-item EASE have demonstrated a 
moderate correlation with the 6MWT (r=0.52 (p < .05) and r=0.57 (P = .001), respectively)11 in a sample 
of 28 children ages 3 to 6 years of age (14 children without CP and 14 children with CP). In our previous 
work, confirmatory factor analysis indicated that the 4-item EASE captured the construct of endurance 
for activity well (Comparative fit index=0.998; Tucker Lewis Index=0.993),11 thus we chose to use it in 
this study to reduce the requested response burden on the parent.  However, additional information on 
the reliability and validity of the 4-item EASE for older children is needed.  
 The Six Minute Walk Test (6MWT)14 is a test of submaximal walking endurance that has been 
used extensively in children and adults. The 6MWT has excellent test-retest reliability (ICC=0.98),2,15 and 
reproduciblility (r=0.87; P=.007; intraclass correlation coefficient [ICC]=0.80) and valid (r=0.948; P<.001) 
in children with CP.16It is often clinically used as a “capacity-based” measure (what child can do in an 
optimized clinical environment) of walking activity.  Fitzgerald and colleagues17 published 6MWT 
reference values for children with spastic CP and children who were developing typically ages 4-17 
years. They reported significant differences in children with CP classified in levels I-III on the Gross 
Motor Function Classification System (GMFCS)18 as compared with children developing typically.  
 The purpose of this study was to describe the EASE and 6MWT scores of young and school-aged 
children with CP by gross motor function classification level, sex, and age. We hypothesized that 
endurance and functional walking capacity would be higher in children with higher gross motor function, 
not differ by sex, and be higher in older children. We also examined the convergent validity of the EASE 
to the 6MWT scores to examine how closely these two measures are related. The results should provide 
evidence-based data to evaluate endurance and monitor change over time for children with CP. 
Methods 
 This study was part of a multisite, prospective cohort study entitled ‘On Track: Monitoring 
Development of Children with Cerebral Palsy and Gross Motor Delay,’ which aimed to develop 
longitudinal developmental curves and reference percentiles for impairments, health conditions, and 
participation variables for children with cerebral palsy. The full study protocol, reported elsewhere,19 
was reviewed and approved by the Institutional Review Boards (IRB) at all participating institutions and 
recruitment sites. All parents or guardians provided informed consent and children, as appropriate and 
in compliance with the specific IRB, provided assent. EASE and 6MWT data from the first assessment are 
analyzed and reported within this paper. 
Participants 
 A convenience sample of 708 children with CP ages 18-months up to the 12th birthday at study 
onset, GMFCS Levels I-V participated in completing the EASE in this study. A smaller cohort of 376 of the 
study participants, ages 3 up to the child’s 12th birthday (mean = 82.0 months, SD = 26.9 months), 
GMFCS Levels I (n=176), II (n=138), and III (n=62) also participated in the 6MWT. Children were recruited 
from across Canada, including Ontario, Newfoundland, Manitoba, Alberta, and British Columbia, and 
four regions within the United States, including areas in and around, Georgia, Oklahoma, Pennsylvania, 
and Washington. Participating children had a diagnosis of CP by a physician or demonstrated delay in 
gross motor development in addition to impairments in: muscle tone, righting and equilibrium reactions, 
anticipatory postural movements of the head, trunk, or legs during movement, and active range of 
motion during movements. Children were excluded if their parents were unable to speak and 
understand English, French or Spanish. Demographic information of the children and their families is 
included in Table 1.  
Procedure 
 At the initial On Track assessment session, the therapist and parent determined the child’s 
GMFCS level via a consensus process.20 The GMFCS is a five-point classification system used to describe 
gross motor function ability in children with CP.18 Distinctions between levels of the GMFCS are based on 
the need for assistive devices and caregiver assistance. Inter-rater reliability, content and construct 
validity, 18 and stability21 of the GMFCS for use with children with CP has been supported in the 
literature.  Additionally, the excellent reliability (ICC = 0.94) between therapist and family report for the 
GMFCS has also been established.22    
 Consensus on the GMFCS classification between the therapist and the parent was achieved 
98.7% of the time. In most cases where disagreements occurred, the parent’s classification was used for 
analysis, and formal rules existed to determine instances where the assessor’s classification should be 
used instead.20 These rules included situations where the assessor had written a compelling description 
of the child’s capability that was lower than the parent-assigned GMFCS level, report of the use of the 
incorrect age band for the GMFCS leading to an inaccurate classification, or assessor report that the 
parent was not ready to participate in a discussion of consensus regarding GMFCS levels.20   
 The parents of all participants (GMFCS levels I-V) completed the EASE either online or within a 
parent booklet. The smaller cohort of 376 of the study participants also completed the 6MWT with 
trained and reliable therapist assessors. Assessors included 90 licensed physical and occupational 
therapists in the communities where the children resided. They participated in a training session prior to 
collecting data. For the 6MWT, the child was permitted to wear orthoses, if regularly used, and to use an 
assistive mobility device, selecting the device that allowed for the most sustained walking cadence or 
was typically be used for long walks. Assessors were instructed to select a walking course either indoors 
or outdoors on a large (about 100 feet), flat (no hills or bumps), hard terrain (asphalt, pavement) that 
would not require the child to make a 180-degree turn. The starting line was marked prior to beginning 
the 6MWT, to allow for re-measurement, if needed. Standardized instructions were then used to 
describe the 6MWT to the child, encouraging the child to walk as far as he/she could in 6 minutes.  The 
distance walked was measured using a calibrated measuring wheel, and a stopwatch was used to keep 
track of the allocated time. Assessors provided pre-established verbal encouragements to the child at 
each minute to encourage the child to keep going and do his/ her best. Conversations with the child 
were limited so as not to impact or slow the walking pace. Assessors recorded the total number of feet 
walked in 6-minutes.  
 Data Analysis 
 Descriptive data for the EASE and 6MWT distances were computed for children grouped by 
GMFCS level (I-V), by age (18-months to 3 years, 3 to 6 years, 6 to 9 years, and 9 to 11 years), and 
between boys and girls. Parametric statistics were used as the data demonstrated normal distributions. 
A two-way ANOVA examining GMFCS by age interactions was completed, showing interactions were not 
significant. Therefore, one-way ANOVA with post hoc Tukey tests were used to compare EASE scores 
and 6MWT distances among GMFCS levels and age groupings. Independent t-tests were used to 
examine differences between boys and girls. Convergent validity of the EASE and 6MWT was assessed 
using Pearson’s r correlations for children classified as GMFCS levels I-III as a group and then individually 
by level.  
Results  
 Descriptive statistics are presented in Table 2. Mean EASE scores differed based on children’s 
GMFCS levels (p<.001) except between Levels II and III (p=.09). Higher EASE scores, representing greater 
perceived endurance for activity, were reported for children with higher gross motor function. Children 
aged 1.5- to 3-years and 3- to 6-years had significantly lower EASE scores than children 9- to 12-years 
(p=.01 and p<.001, respectively). No differences were noted between the other age groupings. EASE 
scores were not significantly different between boys and girls (p=.11). See Figure 1.  
< Insert Figure 1 about here> 
 On the 6MWT, children in GMFCS levels I, II, and III on average walked 1259.3 feet (383.8 
meters), 922.0 feet (281.0 meters), and 545.8 feet (166.4 meters), respectively. Significant differences in 
distance walked were noted across all GMFCS levels I-III (p<.001). Differences in walking distance were 
noted across some of the age groupings (p <.001). Children 3-6 years walked significantly less than 
children 6-9 years (p<.001) and 9-11 years (p<.001). No differences were noted in walking distance 
between children 6-9 and 9-11 years (p=.29).  Distance walked did not differ between girls and boys 
(p=0.43). (See Figure 2). 
<Insert Figure 2 about here> 
 The EASE and 6MWT demonstrated a statistically significant but low, positive correlation (r=.30, 
p<.001) across GMFCS levels I-III, indicating that the EASE and 6MWT appear to measure different 
constructs. Correlations between the EASE and 6MWT by individual GMFCS levels demonstrated low, 
non-significant correlations of r=.14 for GMFCS level I, r=.07 for GMFCS level II, and r=.02 for GMFCS 
level III. (See Table 3) 
<Insert Table 3 about here> 
Discussion 
 Parent perceived endurance for activity, as measured by the EASE, differed across GMFCS levels 
with higher EASE scores reported for children with higher gross motor function; however, parents of 
children in GMFCS Levels II and III reported similar perceived endurance. This finding is consistent with 
the results of initial construct validity testing on the original 10-item EASE completed by McCoy and 
colleagues10 who also reported significant differences across GMFCS levels (p<.001), except between 
levels II and III (p=.62) for young children with CP. This may suggest that children in GMFCS levels II and 
III demonstrate similar endurance levels for activity, or that the EASE is not sensitive enough to detect 
the variations in endurance for activity between these two levels. Younger children, under 6-years of 
age, were reported to have higher endurance than children 9-12 years of age. This decrease in 
endurance in older children with CP has been frequently noted in the literature.6-8 EASE scores were not 
different between sexes, which is again consistent with the findings of McCoy and colleagues.10   
 Functional walking capacity, as measured by the 6MWT, increased based on children’s walking 
ability, children classified in GMFCS level I (walks in all settings) walked a greater distance than children 
classified in GMFCS level II (difficulty walking long distances) or level III (walks with hand held mobility 
device). Children classified in GMFCS level II (difficulty walking long distances) walked a greater distance 
than children in GMFCS level III (walks with hand held mobility device). This finding is consistent with 
previous research that also reported significant differences across GMFCS levels,14, 16 and may represent 
the increasing energy cost23 and physical demand associated with walking for children in levels II and III.  
 Our hypothesis that walking capacity would increase with age was partially supported. Younger 
children in our sample (ages 3-6 years) walked significantly less distance than older children (ages 6-12 
years). However, continued improvement in walking capacity was not noted between the two older 
groups of children. This finding may reflect that younger children with CP are still developing and 
refining their gross motor abilities, typically reaching their functional plateau by five years of age.24 As 
expected, there was no difference by sex. 
 The mean 6MWT distances in this study (GMFCS level I: 1259.3 feet (383.8 meters), GMFCS level 
II: 922.0 feet (281.0 meters), and GMFCS level III 545.8 feet (166.4 meters) are substantially lower than 
what was previously reported for children with CP. Thompson and colleagues14 reported mean distances 
of 486.6 meters, 312.9 meters, and 240.2 meters 4-18 year old children with CP in GMFCS levels I, II, and 
III, respectively. Fitzgerald and colleagues17 reported mean distances of 439.57 meters, 386.74 meters, 
and 305.28 meters for 4-17 year old children with CP in GMFCS levels I, II, and III, respectively. These 
studies included children up to 17 or 18 years of age, which represents an older sample than examined 
in this current study, and this may account for some of the variations noted in the distances walked. The 
study walking distances may also have been impacted by the location of testing within the natural home 
or clinic environment, as opposed to within a standardized testing track used for all participants. 
Additional research investigating these differences with an older sample of children is needed.     
 Scores on the EASE and 6MWT demonstrated a significant but low correlation across GMFCS 
level I-III and non-significant, low correlations when examining the GMFCS levels individually. This 
suggests that the EASE and 6MWT appear to assess different specific constructs associated with 
endurance for activity. The 6MWT is often used as a measure of functional walking capacity and may not 
clearly assess endurance for activity for children using a variety of forms of mobility rather than just 
walking. The EASE is a proxy measure for endurance for activity that is based on the parent’s perception 
of the child’s endurance ability, which introduces some variability in the measurement. For children in 
GMFCS levels I and II, the EASE may provide information related to general endurance for activity, but 
does not specifically capture walking capacity. The EASE also includes elements of frequency and 
intensity of a variety of physical activities, and may be a better measure for use with children at GMFCS 
levels III-V.  Use of both measures may be important for children in GMFCS level III.  
Clinical Relevance  
 We recommend therapists consider the impact of GMFCS level and age on endurance and 
functional walking capacity of children with CP and tailor intervention programs to specifically address 
these impairments. We also recommend therapists consider the use of standardized measures such as 
the EASE and 6MWT to assess and monitor endurance and functional walking capacity of children with 
CP to assist with appropriate intervention planning. Because of low convergent validity, consideration of 
the construct of interest is needed if choosing between the EASE and 6MWT for children with CP. 
Careful attention to preventing a decline in endurance and walking capacity may allow for increased 
participation in life activities for children with CP.  
 Limitations  
 Participants in this study were recruited as a sample of convenience, which presents a potential 
limitation; however, the GMFCS distribution of the larger On Track study participants is comparable to 
incidence data reported in the literature, supporting the applicability of the findings.26 Variations in the 
location of the 6MWT, due to weather or family relocation, and testing within the natural environment 
may have impacted the distance walked for some children. Additionally, this study investigated the 
shorter 4-item EASE, as opposed to the 10-item EASE, which demonstrated moderate correlation to the 
6MWT in our previous work.10 More research is needed to determine the reliability and validity of the 
EASE in older children. 
Conclusion 
 Children with CP present with variations in endurance and functional walking capacity based on 
GMFCS level and, to a lesser extent, age.  The EASE and 6MWT are standardized assessments measuring 
two different constructs, endurance and walking capacity respectively, which provide clinicians with 
information that contributes to a comprehensive assessment of a child’s functional abilities. 
Understanding the relationship between these outcomes and GMFCS levels and age, assists clinicians 
with setting goals and creating intervention programs targeted at improving endurance for activity and 
functional walking capacity. Children with CP who have greater endurance are afforded more 
opportunities for participation in the community. As therapists develop intervention programs, careful 
attention to monitoring and preventing a decline in endurance and walking capacity may allow for 
increased participation in life activities for children with CP.  
 
References 
1. van den Berg-Emons HJ, Saris WH, de Barbanson DC, Westerterp KR, Huson A, van Baak MA.  
Daily physical activity of schoolchildren with spastic diplegia and of healthy control subjects. J 
Pediatr. 1995; 127:578-584. 
2. Maher CA, Williams MT, Olds TS. The six-minute walk test for children with cerebral palsy. 
Internat J Rehabil Res. 2008;31:185-188. 
3. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise and physical fitness: 
definitions and distinctions for health-related research. Public Health Rep. 1985; 100: 126–131. 
4. Rimmer JH. Physical fitness levels of persons with CP. Dev Med Child Neurol. 2001;43:208 –212. 
5. Damiano DL. Strength, endurance and fitness in CP. Quebec Abstr. 2003;8 –10. 
6. Maltais DB, Pierrynowski MR, Galea VA, Bar-Or O. Physical activity level is associated with O2 
cost of walking in cerebral palsy. Med Sci Sports Exerc. 2005;37:347–353. 
 
7. Johnston TE, Moore SE, Quinn LT, Smith BT. Energy cost of walking in children with cerebral 
palsy: relation to the Gross Motor Function Classification System. Dev Med Child Neurol. 
2004;46:34–38. 
 
8. Johnson DD, Damiano DL, Abel MF. The evolution of gait in childhood and adolescent cerebral 
palsy. J Pediatr Orthop. 1997; 17:392–396. 
 
9. Fauconnier J, Dickinson HO, Beckung E, et al. Participation in life situations of 8-12 year old 
children with cerebral palsy: cross sectional European study BMJ. 2009; 338 :b1458  
  
10. McCoy SW, Yocum A, Bartlett DJ, et al. Development of the Early Activity Scale for Endurance for 
children with cerebral palsy. Pediatr Phys Ther. 2012; 24:232-240.  
 
11. Mendoza JM, McCoy SW, Zygmuntowicz E, Kevan B, Katsel E, Move and PLAY team. Reliability 
and validity of an endurance questionnaire in young children with cerebral palsy. Pediatr Phys 
Ther. 2010;22:128. 
 
12. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards 
for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med 2002; 166: 111–117. 
  
13. Jeffries L, Fiss AL, McCoy SW, Bartlett DJ. Description of primary and secondary impairments in 
young children with cerebral palsy. Pediatr Phys Ther. 2016;28:7-14.  
 
14. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards 
for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med 2002; 166: 111–117. 
 
15. Thompson P, Beath T, Bell J, et al. Test-retest reliability of the 10-metre fast walk test and 6-
minute walk test in ambulatory school-aged children with cerebral palsy. Dev Med Child Neurol. 
2008;50(5):370-376.  
16. Nsenga Leunkeu A, Shephard RJ, Ahmaidi S. Six-minute walk test in children with cerebral palsy 
Gross Motor Function Classification System levels I and II: reproducibility, validity, and training 
effects. Arch Phys Med Rehabil. 2012;93:2333-2339. 
17. Fitzgerald D, Hickey C, Delahunt E, Walsh M, O’Brien T. Six-minute walk test in children with 
spastic cerebral palsy and children developing typically. Pediatr Phys Ther. 2016; 28:192-199. 
 
18. Palisano R, Rosenbaum P, Bartlett D, Livingston M. Content validity of the expanded and revised 
Gross Motor Function Classification System. Dev Med Child Neurol. 2008; 50:744-750. 
  
19. McCoy SW, Bartlett D, Smersh M, Galuppi B, Hanna S, Collaboration Group: On Track Study 
Team. Monitoring development of children with cerebral palsy: the On Track study. Protocol of a 
longitudinal study of development and services. Available at: 
https://www.canchild.ca/en/resources/294-monitoring-development-of-children-with-cerebral-
palsy-the-on-track-study-protocol-of-a-longitudinal-study-of-development-and-services. 
Accessed March 21, 2018. 
 
20. Bartlett DJ, Galuppi B, Palisano RJ, McCoy SW. Consensus classifications of gross motor, manual 
ability, and communication function classification systems between therapists and parents of 
children with cerebral palsy. Dev Med Child Neurol. 2016; 58:98-99.  
 
21. Alriksson-Schmidt A, Nordmark E, Czuba T, Westbom L. Stability of the Gross Motor Function 
Classification System in children and adolescents with cerebral palsy: a retrospective cohort 
registry study. Dev Med Child Neurol. 2017;59:641-646.  
 
22. Morris C, Galuppi BE, Rosenbaum PL. Reliability of family report for the Gross Motor Function 
Classification System. Dev Med Child Neurol. 2004;46:455-460. 
 
23. Johnston TE, Moore ST, Quinn LT, Smith B. Energy cost of walking in children with cerebral palsy: 
Relation to the Gross Motor Function Classification System. Dev Med Child Neurol. 2004;46:34-8.  
 
24. Rosenbaum PL, Walter SD, Hanna SE, et al. Prognosis for gross motor function in cerebral palsy: 
creation of motor development curves. JAMA.  2002;288:1357-1363.  
 
25. Klepper SE, Muir N. Reference values on the 6-minute walk test for children living in the United 
States. Pediatr Phys Ther. 2011; 23:32-40. 
 
26. Reid SM, Carlin JB, Reddihough DS. Using the Gross Motor Function Classification System to 
describe patterns of motor severity in cerebral palsy. Dev Med Child Neurol. 2011; 53:1007-
1012. 
 
 
 Figure 1. EASE Comparisons 
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Table 1. Child and Parent Demographics  
 Participants 
 EASE 
n=708 (%) 
6MWT 
n=376 (%) 
Child Gender 
EASE (n = 707) 
6MWT (n = 376) 
Male 396 (56) 209 (56) 
Female 312 (44) 167 (44) 
Child GMFCS Level 
EASE (n = 707) 
6MWT (n = 376) 
 
I 227 (32) 176 (47) 
II 161 (23) 138 (37) 
III 80 (11) 62 (17) 
IV 129 (18)  
V  111 (16)  
Child Distribution of 
Involvement*  
EASE (n = 707) 
6MWT (n = 376) 
 
Monoplegia  8  (1) 4 (1) 
Hemiplegia 198 (28) 159 (42) 
Diplegia 184 (26) 139 (37) 
Triplegia  39  (6) 23 (6) 
Quadriplegia 278 (39) 51 (14) 
Child race* American Indian/Alaska Native 15  (2) 8 (2) 
Figure 2. 6MWT Comparison 
   6MWT by GMFCS Level       6MWT Distance by Age Group 
 
6MWT Distances by Sex 
 
EASE (n = 699) 
6MWT (n = 368) 
 
Asian 40  (6) 23 (6) 
Black/African American 60  (8) 25 (6) 
White 503 (72) 276 (74) 
Multi 81 (12) 36 (10) 
Child ethnicity* 
EASE (n = 703) 
6MWT (n = 372) 
 
Hispanic 49  (7) 26 (7) 
Non-Hispanic 654 (93) 346 (92) 
   
Aboriginal 31  (4) 357 (95) 
Non-Aboriginal 672 (96) 16 (4) 
Parent respondent race* 
EASE (n = 698) 
6MWT (n=369) 
American Indian/Alaska Native 15  (2) 9 (2) 
Asian 51  (7) 26 (7) 
Black/African American 56  (8) 21 (6) 
White 550 (79) 302 (80) 
Multi 26  (4) 11 (3) 
Parent respondent ethnicity* 
EASE (n = 701) 
6MWT (n = 371) 
 
Hispanic 32  (5) 16 (4) 
Non-Hispanic 669 (95) 355 (94) 
   
Aboriginal 20  (3) 10 (3) 
Non-Aboriginal 681 (97) 361 (96) 
Parent respondent age, years*  
EASE (n=694) 
6MWT (n = 367) 
Mean (SD) 37.8 (7.9) 38.6 (7.8) 
Parent respondent relationship 
to child* 
EASE (n = 704) 
6MWT (n =373) 
Mother 628 (89) 330 (88) 
Father 51  (7) 33  (9) 
Other 25  (4) 10  (3) 
Parent respondent education*  
EASE (n = 700) 
6MWT (n = 370) 
 
High School or less 160 (23) 66 (18) 
Community College / Associate’s 
Degree 
212 (30) 122 (32) 
University 328 (47) 179 (48) 
Family Income* 
EASE (n = 594) 
6MWT (n = 307) 
 
≥$75,000 306 (52) 170 (55) 
$60,000 - $74,999 78 (13) 40 (13) 
$45,000 - $59,999 50  (8) 23 (8) 
$30,000 - $44,999 58  (10) 24 (8) 
≤$30,000 102 (17) 50 (16) 
Country 
EASE (n=708) 
6MWT (n=373) 
Canada 347 (49) 192 (51) 
United States 361 (51) 184 (49) 
GMFCS= Gross Motor Function Classification System Level  
CAD = Canadian Dollars 
USD = United States Dollars 
SD = standard deviation 
* report based on the available information 
Notes: ‘mother’ includes mother, adoptive mother, foster mother, or custodial mother; ‘father’ includes 
father, adoptive father, or step father; ‘other’ includes grandparent, nursing supervisor, or aunt. 
 
 
 
 
 
Table 2. Mean EASE Scores and 6MWT Distances and Pairwise Comparisons 
EASE 
GMFCS Mean (SD) Comparison p-value 
Level I 
(n=227) 
3.9 (.7) Level II 
Level III 
Level IV 
Level V 
< .001 
< .001 
< .001 
< .001 
Level II 
(n=161) 
3.4 (.8) Level III 
Level IV 
Level V 
.09 
< .001 
 < .001 
Level III 
(n=80) 
3.1 (.8) Level IV 
Level V 
.01 
< .001 
Level IV 
(n=129) 
2.7 (.9) Level V < .001 
 
Level V 
(n=111) 
1.8 (.9)   
Age Mean (SD) Comparison p-value 
18 months - 3 years 
(n=131) 
3.3 (1.1) 3-6 years 
6-9 years 
9-12 years 
.99 
.33 
.01 
3-6 years 
(n=216) 
3.3 (1.0) 6-9 years 
9-12 years 
.11 
.001 
6-9 years 
(n=246) 
3.1 (1.0) 9-12 years .17 
9-12 years 
(n=115) 
2.9 (1.0)   
Sex Mean (SD) Comparison p-value 
Male 
(n=396) 
3.2 (1.1) Female .11 
Female 
(n=312) 
3.1 (1.1)   
6MWT 
GMFCS Mean (SD) in feet 
Mean (SD) in meters 
Comparison p-value 
Level I 
(n=176) 
1259.3 (349.3) 
383.8 (106.5) 
Level II 
Level III 
< .001 
 < .001 
Level II 922.0 (358.1) Level III < .001 
(n=138) 281.0 (109.2)   
Level III 
(n=62) 
545.8 (324.9) 
166.4 (99.0) 
  
Age Mean (SD) in feet 
Mean (SD) in meters 
Comparison p-value 
3-6 years 
(n=141) 
852.9 (397.1) 
260.0 (121.0) 
6-9 years 
9-12 years 
< .001 
 < .001 
6-9 years 
(n=157) 
1088.2 (423.6) 
332.0 (129.1) 
9-12 years .29 
9-12 years 
(n=78) 
1174.4 (428.1) 
358.0 (130.5) 
  
Sex Mean (SD) in feet 
Mean (SD) in meters 
Comparison p-value 
Male 
(n=209) 
1033.5 (437.3) 
315.0 (133.3) 
Female .43 
Female 
(n=167) 
998.2 (430.8) 
304.3 (131.3) 
  
 
 
Table 3. Correlations Between the 6MWT Distances and EASE Scores 
GMFCS (n) Pearson r p-value 
Level I (176) .14 .06 
Level II (138) .07 .44 
Level III (62) .02 .88 
Total .30 P<.001* 
* Indicates significance at p>.05 level 
 
 
 
